Connection
Co-Authors
This is a "connection" page, showing publications co-authored by Frederick Masoudi and Pamela Peterson.
|
|
Connection Strength |
|
 |
|
 |
|
8.586 |
|
|
|
-
Peterson PN, Greenlee RT, Go AS, Magid DJ, Cassidy-Bushrow A, Garcia-Montilla R, Glenn KA, Gurwitz JH, Hammill SC, Hayes J, Kadish A, Reynolds K, Sharma P, Smith DH, Varosy PD, Vidaillet H, Zeng CX, Normand ST, Masoudi FA. Comparison of Inappropriate Shocks and Other Health Outcomes Between Single- and Dual-Chamber Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac Death: Results From the Cardiovascular Research Network Longitudinal Study of Implantable Cardioverter-Defibrillators. J Am Heart Assoc. 2017 Nov 09; 6(11).
Score: 0.681
-
Peterson PN, Greiner MA, Qualls LG, Al-Khatib SM, Curtis JP, Fonarow GC, Hammill SC, Heidenreich PA, Hammill BG, Piccini JP, Hernandez AF, Curtis LH, Masoudi FA. QRS duration, bundle-branch block morphology, and outcomes among older patients with heart failure receiving cardiac resynchronization therapy. JAMA. 2013 Aug 14; 310(6):617-26.
Score: 0.508
-
Peterson PN, Varosy PD, Heidenreich PA, Wang Y, Dewland TA, Curtis JP, Go AS, Greenlee RT, Magid DJ, Normand SL, Masoudi FA. Association of single- vs dual-chamber ICDs with mortality, readmissions, and complications among patients receiving an ICD for primary prevention. JAMA. 2013 May 15; 309(19):2025-34.
Score: 0.499
-
Peterson PN, Campagna EJ, Maravi M, Allen LA, Bull S, Steiner JF, Havranek EP, Dickinson LM, Masoudi FA. Acculturation and outcomes among patients with heart failure. Circ Heart Fail. 2012 Mar 01; 5(2):160-6.
Score: 0.455
-
Peterson PN, Shetterly SM, Clarke CL, Bekelman DB, Chan PS, Allen LA, Matlock DD, Magid DJ, Masoudi FA. Health literacy and outcomes among patients with heart failure. JAMA. 2011 Apr 27; 305(16):1695-701.
Score: 0.433
-
Peterson PN, Magid DJ, Lyons EE, Clarke CL, Zeng C, Fitzgerald A, Lindenfeld J, Kosiborod M, Brand D, Masoudi FA. Association of longitudinal measures of hemoglobin and outcomes after hospitalization for heart failure. Am Heart J. 2010 Jan; 159(1):81-9.
Score: 0.395
-
Peterson PN, Ambardekar AV, Jones PG, Krumholz HM, Schelbert E, Spertus JA, Rumsfeld JS, Masoudi FA. Increased mortality among survivors of myocardial infarction with kidney dysfunction: the contribution of gaps in the use of guideline-based therapies. BMC Cardiovasc Disord. 2009 Jul 08; 9:29.
Score: 0.382
-
Peterson PN, Magid DJ, Ross C, Ho PM, Rumsfeld JS, Lauer MS, Lyons EE, Smith SS, Masoudi FA. Association of exercise capacity on treadmill with future cardiac events in patients referred for exercise testing. Arch Intern Med. 2008 Jan 28; 168(2):174-9.
Score: 0.346
-
Peterson PN, Masoudi FA. Cardiovascular disease and the elderly: can the evidence base avoid irrelevance? Eur Heart J. 2007 Jun; 28(11):1277-8.
Score: 0.329
-
Borne RT, Varosy P, Lan Z, Masoudi FA, Curtis JP, Matlock DD, Peterson PN. Trends in Use of Single- vs Dual-Chamber Implantable Cardioverter-Defibrillators Among Patients Without a Pacing Indication, 2010-2018. JAMA Netw Open. 2022 03 01; 5(3):e223429.
Score: 0.230
-
Borne RT, Masoudi FA, Curtis JP, Zipse MM, Sandhu A, Hsu JC, Peterson PN. Use and Outcomes of Dual Chamber or Cardiac Resynchronization Therapy Defibrillators Among Older Patients Requiring Ventricular Pacing in the National Cardiovascular Data Registry Implantable Cardioverter Defibrillator Registry. JAMA Netw Open. 2021 01 04; 4(1):e2035470.
Score: 0.212
-
Kini V, Peterson PN, Spertus JA, Kennedy KF, Arnold SV, Wasfy JH, Curtis JP, Bradley SM, Amin AP, Ho PM, Masoudi FA. Clinical Model to Predict 90-Day Risk of Readmission After Acute Myocardial Infarction. Circ Cardiovasc Qual Outcomes. 2018 10; 11(10):e004788.
Score: 0.181
-
Greenlee RT, Go AS, Peterson PN, Cassidy-Bushrow AE, Gaber C, Garcia-Montilla R, Glenn KA, Gupta N, Gurwitz JH, Hammill SC, Hayes JJ, Kadish A, Magid DJ, McManus DD, Multerer D, Powers JD, Reifler LM, Reynolds K, Schuger C, Sharma PP, Smith DH, Suits M, Sung SH, Varosy PD, Vidaillet HJ, Masoudi FA. Device Therapies Among Patients Receiving Primary Prevention Implantable Cardioverter-Defibrillators in the Cardiovascular Research Network. J Am Heart Assoc. 2018 03 26; 7(7).
Score: 0.175
-
Borne RT, Katz D, Betz J, Peterson PN, Masoudi FA. Implantable Cardioverter-Defibrillators for Secondary Prevention of Sudden Cardiac Death: A Review. J Am Heart Assoc. 2017 03 03; 6(3).
Score: 0.162
-
Betz JK, Katz DF, Peterson PN, Borne RT, Al-Khatib SM, Wang Y, Hansen CM, McManus DD, Mathew JS, Masoudi FA. Outcomes Among Older Patients Receiving Implantable Cardioverter-Defibrillators for Secondary Prevention: From the NCDR ICD Registry. J Am Coll Cardiol. 2017 01 24; 69(3):265-274.
Score: 0.161
-
Katz DF, Peterson P, Borne RT, Betz J, Al-Khatib SM, Varosy PD, Wang Y, Hsu JC, Hoffmayer KS, Kipp RT, Hansen CM, Turakhia MP, Masoudi FA. Survival After Secondary Prevention Implantable Cardioverter-Defibrillator Placement: An Analysis From the NCDR ICD Registry. JACC Clin Electrophysiol. 2017 01; 3(1):20-28.
Score: 0.157
-
Masoudi FA, Go AS, Magid DJ, Cassidy-Bushrow AE, Gurwitz JH, Liu TI, Reynolds K, Smith DH, Reifler LM, Glenn KA, Fiocchi F, Goldberg R, Gupta N, Peterson PN, Schuger C, Vidaillet H, Hammill SC, Greenlee RT. Age and sex differences in long-term outcomes following implantable cardioverter-defibrillator placement in contemporary clinical practice: findings from the Cardiovascular Research Network. J Am Heart Assoc. 2015 Jun 02; 4(6):e002005.
Score: 0.144
-
Heidenreich PA, Tsai V, Bao H, Curtis J, Goldstein M, Curtis L, Hernandez A, Peterson P, Turakhia MP, Masoudi FA. Does Age Influence Cardiac Resynchronization Therapy Use and Outcome? JACC Heart Fail. 2015 Jun; 3(6):497-504.
Score: 0.143
-
Borne RT, Peterson PN, Greenlee R, Heidenreich PA, Wang Y, Curtis JP, Tzou WS, Varosy PD, Kremers MS, Masoudi FA. Temporal trends in patient characteristics and outcomes among Medicare beneficiaries undergoing primary prevention implantable cardioverter-defibrillator placement in the United States, 2006-2010. Results from the National Cardiovascular Data Registry's Implantable Cardioverter-Defibrillator Registry. Circulation. 2014 Sep 02; 130(10):845-53.
Score: 0.136
-
Masoudi FA, Mi X, Curtis LH, Peterson PN, Curtis JP, Fonarow GC, Hammill SC, Heidenreich PA, Al-Khatib SM, Piccini JP, Qualls LG, Hernandez AF. Comparative effectiveness of cardiac resynchronization therapy with an implantable cardioverter-defibrillator versus defibrillator therapy alone: a cohort study. Ann Intern Med. 2014 May 06; 160(9):603-11.
Score: 0.133
-
Clarke CL, Grunwald GK, Allen LA, Bar?n AE, Peterson PN, Brand DW, Magid DJ, Masoudi FA. Natural history of left ventricular ejection fraction in patients with heart failure. Circ Cardiovasc Qual Outcomes. 2013 Nov; 6(6):680-6.
Score: 0.128
-
Peterson PN, Chan PS, Spertus JA, Tang F, Jones PG, Ezekowitz JA, Allen LA, Masoudi FA, Maddox TM. Practice-level variation in use of recommended medications among outpatients with heart failure: Insights from the NCDR PINNACLE program. Circ Heart Fail. 2013 Nov; 6(6):1132-8.
Score: 0.128
-
Dev S, Peterson PN, Wang Y, Curtis JP, Varosy PD, Masoudi FA. Prevalence, correlates, and temporal trends in antiarrhythmic drug use at discharge after implantable cardioverter defibrillator placement (from the National Cardiovascular Data Registry [NCDR]). Am J Cardiol. 2014 Jan 15; 113(2):314-20.
Score: 0.128
-
Bapoje SR, Bahia A, Hokanson JE, Peterson PN, Heidenreich PA, Lindenfeld J, Allen LA, Masoudi FA. Effects of mineralocorticoid receptor antagonists on the risk of sudden cardiac death in patients with left ventricular systolic dysfunction: a meta-analysis of randomized controlled trials. Circ Heart Fail. 2013 Mar; 6(2):166-73.
Score: 0.123
-
Masoudi FA, Go AS, Magid DJ, Cassidy-Bushrow AE, Doris JM, Fiocchi F, Garcia-Montilla R, Glenn KA, Goldberg RJ, Gupta N, Gurwitz JH, Hammill SC, Hayes JJ, Jackson N, Kadish A, Lauer M, Miller AW, Multerer D, Peterson PN, Reifler LM, Reynolds K, Saczynski JS, Schuger C, Sharma PP, Smith DH, Suits M, Sung SH, Varosy PD, Vidaillet HJ, Greenlee RT. Longitudinal study of implantable cardioverter-defibrillators: methods and clinical characteristics of patients receiving implantable cardioverter-defibrillators for primary prevention in contemporary practice. Circ Cardiovasc Qual Outcomes. 2012 Nov; 5(6):e78-85.
Score: 0.120
-
Allen LA, Magid DJ, Zeng C, Peterson PN, Clarke CL, Shetterly S, Brand DW, Masoudi FA. Patterns of beta-blocker intensification in ambulatory heart failure patients and short-term association with hospitalization. BMC Cardiovasc Disord. 2012 Jun 18; 12:43.
Score: 0.117
-
Matlock DD, Peterson PN, Wang Y, Curtis JP, Reynolds MR, Varosy PD, Masoudi FA. Variation in use of dual-chamber implantable cardioverter-defibrillators: results from the national cardiovascular data registry. Arch Intern Med. 2012 Apr 23; 172(8):634-41; discussion 641.
Score: 0.116
-
Matlock DD, Peterson PN, Heidenreich PA, Lucas FL, Malenka DJ, Wang Y, Curtis JP, Kutner JS, Fisher ES, Masoudi FA. Regional variation in the use of implantable cardioverter-defibrillators for primary prevention: results from the National Cardiovascular Data Registry. Circ Cardiovasc Qual Outcomes. 2011 Jan 01; 4(1):114-21.
Score: 0.105
-
Peterson PN, Rumsfeld JS, Liang L, Hernandez AF, Peterson ED, Fonarow GC, Masoudi FA. Treatment and risk in heart failure: gaps in evidence or quality? Circ Cardiovasc Qual Outcomes. 2010 May; 3(3):309-15.
Score: 0.101
-
Peterson PN, Rumsfeld JS, Liang L, Albert NM, Hernandez AF, Peterson ED, Fonarow GC, Masoudi FA. A validated risk score for in-hospital mortality in patients with heart failure from the American Heart Association get with the guidelines program. Circ Cardiovasc Qual Outcomes. 2010 Jan; 3(1):25-32.
Score: 0.098
-
Peterson PN, Daugherty SL, Wang Y, Vidaillet HJ, Heidenreich PA, Curtis JP, Masoudi FA. Gender differences in procedure-related adverse events in patients receiving implantable cardioverter-defibrillator therapy. Circulation. 2009 Mar 03; 119(8):1078-84.
Score: 0.093
-
Ho PM, Peterson PN, Masoudi FA. Evaluating the evidence: is there a rigid hierarchy? Circulation. 2008 Oct 14; 118(16):1675-84.
Score: 0.091
-
Daugherty SL, Peterson PN, Magid DJ, Ho PM, Bondy J, Hokanson JE, Ross CA, Rumsfeld JS, Masoudi FA. The relationship between gender and clinical management after exercise stress testing. Am Heart J. 2008 Aug; 156(2):301-7.
Score: 0.089
-
Ho PM, Eng MH, Rumsfeld JS, Spertus JA, Peterson PN, Jones PG, Peterson ED, Alexander KP, Havranek EP, Krumholz HM, Masoudi FA. The influence of age on health status outcomes after acute myocardial infarction. Am Heart J. 2008 May; 155(5):855-61.
Score: 0.087
-
Masoudi FA, Magid DJ, Vinson DR, Tricomi AJ, Lyons EE, Crounse L, Ho PM, Peterson PN, Rumsfeld JS. Implications of the failure to identify high-risk electrocardiogram findings for the quality of care of patients with acute myocardial infarction: results of the Emergency Department Quality in Myocardial Infarction (EDQMI) study. Circulation. 2006 Oct 10; 114(15):1565-71.
Score: 0.079
-
Annapureddy AR, Henien S, Wang Y, Minges KE, Ross JS, Spatz ES, Desai NR, Peterson PN, Masoudi FA, Curtis JP. Association Between Industry Payments to Physicians and Device Selection in ICD Implantation. JAMA. 2020 11 03; 324(17):1755-1764.
Score: 0.052
-
Borne RT, Randolph T, Wang Y, Curtis JP, Peterson PN, Masoudi FA, Sandhu A, Zipse MM, Thomas K, Kutyifa V, Desai NR, Cha YM, Hsu JC, Russo AM. Analysis of Temporal Trends and Variation in the Use of Defibrillation Testing in Contemporary Practice. JAMA Netw Open. 2019 10 02; 2(10):e1913553.
Score: 0.049
-
Sandhu A, Bao H, Minges KE, Varosy PD, Borne RT, Zipse MM, Marzec L, Peterson P, Masoudi F, Bradley SM. Use of Cardiac Resynchronization Therapy Defibrillator in US Hospitals. JAMA Cardiol. 2019 08 01; 4(8):804-809.
Score: 0.048
-
Hajduk AM, Gurwitz JH, Tabada G, Masoudi FA, Magid DJ, Greenlee RT, Sung SH, Cassidy-Bushrow AE, Liu TI, Reynolds K, Smith DH, Fiocchi F, Goldberg R, Gill TM, Gupta N, Peterson PN, Schuger C, Vidaillet H, Hammill SC, Allore H, Go AS. Influence of Multimorbidity on Burden and Appropriateness of Implantable Cardioverter-Defibrillator Therapies. J Am Geriatr Soc. 2019 07; 67(7):1370-1378.
Score: 0.047
-
Wasfy JH, Kennedy KF, Masoudi FA, Ferris TG, Arnold SV, Kini V, Peterson P, Curtis JP, Amin AP, Bradley SM, French WJ, Messenger J, Ho PM, Spertus JA. Predicting Length of Stay and the Need for Postacute Care After Acute Myocardial Infarction to Improve Healthcare Efficiency. Circ Cardiovasc Qual Outcomes. 2018 09; 11(9):e004635.
Score: 0.045
-
Desai NR, Bourdillon PM, Parzynski CS, Brindis RG, Spatz ES, Masters C, Minges KE, Peterson P, Masoudi FA, Oetgen WJ, Buxton A, Zipes DP, Curtis JP. Association of the US Department of Justice Investigation of Implantable Cardioverter-Defibrillators and Devices Not Meeting the Medicare National Coverage Determination, 2007-2015. JAMA. 2018 07 03; 320(1):63-71.
Score: 0.045
-
Thompson LE, Masoudi FA, Gosch KL, Peterson PN, Jones PG, Salisbury AC, Kosiborod M, Daugherty SL. Gender differences in the association between discharge hemoglobin and 12-month mortality after acute myocardial infarction. Clin Cardiol. 2017 Dec; 40(12):1279-1284.
Score: 0.043
-
Thompson LE, Maddox TM, Lei L, Grunwald GK, Bradley SM, Peterson PN, Masoudi FA, Turchin A, Song Y, Doros G, Davis MB, Daugherty SL. Sex Differences in the Use of Oral Anticoagulants for Atrial Fibrillation: A Report From the National Cardiovascular Data Registry (NCDR?) PINNACLE Registry. J Am Heart Assoc. 2017 Jul 19; 6(7).
Score: 0.042
-
Marzec LN, Peterson PN, Bao H, Curtis JP, Masoudi FA, Varosy PD, Bradley SM. Use of Cardiac Resynchronization Therapy Among Eligible Patients Receiving an Implantable Cardioverter Defibrillator: Insights From the National Cardiovascular Data Registry Implantable Cardioverter Defibrillator Registry. JAMA Cardiol. 2017 05 01; 2(5):561-565.
Score: 0.041
-
Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE, Colvin MM, Drazner MH, Filippatos GS, Fonarow GC, Givertz MM, Hollenberg SM, Lindenfeld J, Masoudi FA, McBride PE, Peterson PN, Stevenson LW, Westlake C. 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. Circulation. 2017 08 08; 136(6):e137-e161.
Score: 0.041
-
Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE, Colvin MM, Drazner MH, Filippatos GS, Fonarow GC, Givertz MM, Hollenberg SM, Lindenfeld J, Masoudi FA, McBride PE, Peterson PN, Stevenson LW, Westlake C. 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the?Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. J Am Coll Cardiol. 2017 08 08; 70(6):776-803.
Score: 0.041
-
Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE, Colvin MM, Drazner MH, Filippatos GS, Fonarow GC, Givertz MM, Hollenberg SM, Lindenfeld J, Masoudi FA, McBride PE, Peterson PN, Stevenson LW, Westlake C. 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the?Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. J Card Fail. 2017 08; 23(8):628-651.
Score: 0.041
-
Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE, Colvin MM, Drazner MH, Filippatos G, Fonarow GC, Givertz MM, Hollenberg SM, Lindenfeld J, Masoudi FA, McBride PE, Peterson PN, Stevenson LW, Westlake C. 2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. Circulation. 2016 09 27; 134(13):e282-93.
Score: 0.038
-
Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE, Colvin MM, Drazner MH, Filippatos G, Fonarow GC, Givertz MM, Hollenberg SM, Lindenfeld J, Masoudi FA, McBride PE, Peterson PN, Stevenson LW, Westlake C. 2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task?Force?on?Clinical Practice Guidelines and the Heart Failure Society of America. J Am Coll Cardiol. 2016 09 27; 68(13):1476-1488.
Score: 0.038
-
Green AR, Leff B, Wang Y, Spatz ES, Masoudi FA, Peterson PN, Daugherty SL, Matlock DD. Geriatric Conditions in Patients Undergoing Defibrillator Implantation for Prevention of Sudden Cardiac Death: Prevalence and Impact on Mortality. Circ Cardiovasc Qual Outcomes. 2016 Jan; 9(1):23-30.
Score: 0.037
-
Khazanie P, Hammill BG, Qualls LG, Fonarow GC, Hammill SC, Heidenreich PA, Al-Khatib SM, Piccini JP, Masoudi FA, Peterson PN, Curtis JP, Hernandez AF, Curtis LH. Clinical effectiveness of cardiac resynchronization therapy versus medical therapy alone among patients with heart failure: analysis of the ICD Registry and ADHERE. Circ Heart Fail. 2014 Nov; 7(6):926-34.
Score: 0.034
-
Allen LA, Shetterly SM, Peterson PN, Gurwitz JH, Smith DH, Brand DW, Fairclough DL, Rumsfeld JS, Masoudi FA, Magid DJ. Guideline concordance of testing for hyperkalemia and kidney dysfunction during initiation of mineralocorticoid receptor antagonist therapy in patients with heart failure. Circ Heart Fail. 2014 Jan; 7(1):43-50.
Score: 0.032
-
Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE, Drazner MH, Fonarow GC, Geraci SA, Horwich T, Januzzi JL, Johnson MR, Kasper EK, Levy WC, Masoudi FA, McBride PE, McMurray JJ, Mitchell JE, Peterson PN, Riegel B, Sam F, Stevenson LW, Tang WH, Tsai EJ, Wilkoff BL. 2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation. 2013 Oct 15; 128(16):1810-52.
Score: 0.031
-
Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE, Drazner MH, Fonarow GC, Geraci SA, Horwich T, Januzzi JL, Johnson MR, Kasper EK, Levy WC, Masoudi FA, McBride PE, McMurray JJ, Mitchell JE, Peterson PN, Riegel B, Sam F, Stevenson LW, Tang WH, Tsai EJ, Wilkoff BL. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation. 2013 Oct 15; 128(16):e240-327.
Score: 0.031
-
Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE, Drazner MH, Fonarow GC, Geraci SA, Horwich T, Januzzi JL, Johnson MR, Kasper EK, Levy WC, Masoudi FA, McBride PE, McMurray JJ, Mitchell JE, Peterson PN, Riegel B, Sam F, Stevenson LW, Tang WH, Tsai EJ, Wilkoff BL. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013 Oct 15; 62(16):e147-239.
Score: 0.031
-
Fitzgerald AA, Powers JD, Ho PM, Maddox TM, Peterson PN, Allen LA, Masoudi FA, Magid DJ, Havranek EP. Impact of medication nonadherence on hospitalizations and mortality in heart failure. J Card Fail. 2011 Aug; 17(8):664-9.
Score: 0.027
-
Peterson ED, DeLong ER, Masoudi FA, O'Brien SM, Peterson PN, Rumsfeld JS, Shahian DM, Shaw RE. ACCF/AHA 2010 Position Statement on Composite Measures for Healthcare Performance Assessment: a report of American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures (Writing Committee to Develop a Position Statement on Composite Measures). J Am Coll Cardiol. 2010 Apr 20; 55(16):1755-66.
Score: 0.025
-
Peterson ED, Delong ER, Masoudi FA, O'Brien SM, Peterson PN, Rumsfeld JS, Shahian DM, Shaw RE, Goff DC, Grady K, Green LA, Jenkins KJ, Loth A, Radford MJ. ACCF/AHA 2010 Position Statement on Composite Measures for Healthcare Performance Assessment: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures (Writing Committee to develop a position statement on composite measures). Circulation. 2010 Apr 20; 121(15):1780-91.
Score: 0.025
-
Stolker JM, Sun D, Conaway DG, Jones PG, Masoudi FA, Peterson PN, Krumholz HM, Kosiborod M, Spertus JA. Importance of measuring glycosylated hemoglobin in patients with myocardial infarction and known diabetes mellitus. Am J Cardiol. 2010 Apr 15; 105(8):1090-4.
Score: 0.025
-
Daugherty SL, Peterson PN, Wang Y, Curtis JP, Heidenreich PA, Lindenfeld J, Vidaillet HJ, Masoudi FA. Use of implantable cardioverter defibrillators for primary prevention in the community: do women and men equally meet trial enrollment criteria? Am Heart J. 2009 Aug; 158(2):224-9.
Score: 0.024
-
Maddox TM, Ross C, Ho PM, Masoudi FA, Magid D, Daugherty SL, Peterson P, Rumsfeld JS. The prognostic importance of abnormal heart rate recovery and chronotropic response among exercise treadmill test patients. Am Heart J. 2008 Oct; 156(4):736-44.
Score: 0.023
-
Ho PM, Magid DJ, Shetterly SM, Olson KL, Maddox TM, Peterson PN, Masoudi FA, Rumsfeld JS. Medication nonadherence is associated with a broad range of adverse outcomes in patients with coronary artery disease. Am Heart J. 2008 Apr; 155(4):772-9.
Score: 0.022
-
Ho PM, Magid DJ, Shetterly SM, Olson KL, Peterson PN, Masoudi FA, Rumsfeld JS. Importance of therapy intensification and medication nonadherence for blood pressure control in patients with coronary disease. Arch Intern Med. 2008 Feb 11; 168(3):271-6.
Score: 0.022
-
Tricomi AJ, Magid DJ, Rumsfeld JS, Vinson DR, Lyons EE, Crounse L, Ho PM, Peterson PN, Masoudi FA. Missed opportunities for reperfusion therapy for ST-segment elevation myocardial infarction: results of the Emergency Department Quality in Myocardial Infarction (EDQMI) study. Am Heart J. 2008 Mar; 155(3):471-7.
Score: 0.021
-
Fadl YY, Krumholz HM, Kosiborod M, Masoudi FA, Peterson PN, Reid KJ, Weintraub WS, Buchanan DM, Spertus JA. Predictors of weight change in overweight patients with myocardial infarction. Am Heart J. 2007 Oct; 154(4):711-7.
Score: 0.021
-
Ho PM, Rumsfeld JS, Peterson PN, Masoudi FA, Strunk A, Ross C, Lyons EE, Smith SS, Lauer MS, Magid DJ. Chest pain on exercise treadmill test predicts future cardiac hospitalizations. Clin Cardiol. 2007 Oct; 30(10):505-10.
Score: 0.021
-
Morgan AL, Masoudi FA, Havranek EP, Jones PG, Peterson PN, Krumholz HM, Spertus JA, Rumsfeld JS. Difficulty taking medications, depression, and health status in heart failure patients. J Card Fail. 2006 Feb; 12(1):54-60.
Score: 0.019
-
Ho PM, Masoudi FA, Peterson PN, Shroyer AL, McCarthy M, Grover FL, Hammermeister KE, Rumsfeld JS. Health-related quality of life predicts mortality in older but not younger patients following cardiac surgery. Am J Geriatr Cardiol. 2005 Jul-Aug; 14(4):176-82.
Score: 0.018
-
Ho PM, Masoudi FA, Spertus JA, Peterson PN, Shroyer AL, McCarthy M, Grover FL, Hammermeister KE, Rumsfeld JS. Depression predicts mortality following cardiac valve surgery. Ann Thorac Surg. 2005 Apr; 79(4):1255-9.
Score: 0.018
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|